Fierce JPM Week

The pharma and biotech industries stand at an inflection point unseen since the genomic revolution. After years of pandemic-fueled growth and subsequent market turmoil, companies are redefining how they will survive and thrive. Capital is scarcer. Regulators worldwide are rewriting the rules. Breakthrough therapies in oncology, rare diseases and obesity are upending competition, even as supply chains fray and manufacturing nationalism redraws the global map. In this moment of transformation, the industry's most consequential choices are being made. Which platforms will set the pace for the next decade? How will artificial intelligence reshape the economics of drug discovery? Can emerging companies secure the funding to deliver new treatments to patients? At Fierce JPM Week 2026, the sector's most influential leaders, investors and policymakers will convene to confront these questions and chart the course ahead.